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ABSTRACT 
Background: Protein oxidation can occur as a consequence of lipid peroxidation during food processing. 
The aim of this work was to explore the effect of malondialdehyde (MDA) modification of ovalbumin 
(OVA) on its interaction with T84 intestinal cells.  
Methods: Molecular dynamics simulation was employed for the prediction of MDA modification in the 
OVA, while introduced structural changes were evaluated by measurement of carbonyl group content, 
fluorescence spectra, MS/MS analysis, and IgE reactivity. Effects of MDA modified OVA on T84 
epithelial cells were analyzed by gene expression for pro-inflammatory cytokines and protein secretion. 
Results: Out of 9 predicted, five modified Lys residues were confirmed by MS/MS analysis: 
51
TQINKVVR
58
, 
85
DILNQITKPNDVYSFSLASR
104
, 
111
YPILPEYLQCVKELYR
126
, 
187
AFKDEDTQAMPFR
199
, 
277
KIKVYLPR
284
, and 
278
IKVYLPR
284
. The introduced MDA modifications 
influenced profile of IgE reactivity to OVA. Treatment of T84 epithelial cells with OVA and OVA 
modified with 1 mM MDA, induced up-regulation of pro-inflammatory cytokines (IL-1β, IL-25, IL-33, 
TSLP and TNFα), while OVA modification with 10 mM MDA induced down regulation of the cytokine 
expression profile, except for IL-1β. OVA and OVA modified with 1 mM MDA induced secretion of 
epithelial cells specific cytokine IL-33. 
Conclusions: This finding indicated that OVA and its MDA modified form have the potential to trigger 
the innate immunity by inducing up-regulation and secretion of pro-allergenic IL-33 in T84 intestinal 
epithelial cells. 
General significance: Interactions of ovalbumin and its MDA modified form with intestinal epithelial 
cells can induce a specific immunological priming necessary for the downstream activation of innate 
immunity. 
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Abbreviations: DNPH, 2,4-dinitrophenylhydrazine; DC, dendritic cell; DHP, dihydropyridine; IgE, 
immunoglobulin E; IgG, immunoglobulin G; MDA, malondialdehyde; MD, molecular dynamics; OVA, 
ovalbumin; TSLP, thymic stromal lymphopoietin; TNFα, tumor necrosis factor α. 
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1. Introduction 
Food allergy is a growing public health concern in the Western society that affects 3-8% of children and 
1-3% of the adult population [1,2]. Hen eggs are generally regarded as one of nature’s perfect foods 
which contain a unique and well-balanced mix of essential nutrients however, they are among the top 
eight food allergen sources that induce a wide range of clinical manifestations of type I hypersensitivity 
reaction which are particularly prevalent in the pediatric population [3]. The molecular basis for hen egg 
allergy is attributed to seven registered allergens from Gallus domesticus (www.allergen.org), with the 
following allergens as predominant: ovomucoid (Gal d 1), ovalbumin (Gal d 2), ovotransferrin (Gal d 3) 
and lysozyme (Gal d 4) [4,5]. Among this protein panel, ovalbumin is the most abundant, representing 
54% of the egg white proteins.  
Ovalbumin (Gal d 2, OVA) is a polypeptide of 385 amino acid residues [6]. OVA shares sequence 
identity with protease inhibitors of the serpin family, including antitrypsin [7], but it lacks protease 
inhibitory activity. It is a phosphoglycoprotein having carbohydrate (3% by weight) and phosphate 
moieties attached to the polypeptide. The protein conformation is stabilized by one disulfide bond 
(Cys74-Cys121), and contains four free thiol (SH) groups (Cys11, Cys30, Cys367, and Cys382), which 
sometimes causes dimerization, while the amino terminus of the protein is acetylated [8]. The post-
translational modifications of OVA increase the sequence-derived molecular mass of 42750 Da to 44000-
45000 Da [9]. Five immunodominant IgE-binding epitopes were detected in OVA: AA38-49, AA95-102, 
AA191-200, AA243-248, and AA251-260 [10]. In a recent study seven IgE-reactive peptides were 
detected in the OVA after digestion with human and simulated gastroduodenal fluids: AA125-134, 
AA141-154, AA159-172, AA164-176, AA188-198, AA326-336, and AA370-385. In the group of egg 
allergic persons, 80% were positive to the peptide AA370-385 [11].  
Food processing can have an impact on the IgG- and IgE-binding properties of food proteins and 
consequently on their ability to elicit allergic reactions. However, much less information is available on 
the impact of food processing on the potential of a protein to induce the immunological priming, 
necessary for the induction of IgE antibody responses and the acquisition of allergenic sensitization. 
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During the food processing, generation of lipid peroxidation end-products can cause protein 
deteriorations, including changes in the allergenic properties [12]. Malondialdehyde (MDA), very often 
the most abundant product of lipid peroxidation, can cause protein damage by reacting with lysine amino 
group, cysteine sulfhydryl group, arginine guanidine group and histidine imidazole moiety [13]. Effects of 
aldehydes are important because of their propensity to form Schiff bases with amino groups, and in 
particular the bifunctional MDA can modify and cross-link protein via Schiff base formation [14]. MDA 
reacts with lysine generating N-(2-propenal)lysine (N-propenal-Lys), and also forms fluorescent products 
such as the dihydropyridine (DHP)-type adducts [15], which are often found in proteins after lipid 
peroxidation. 
Epithelial cells play a crucial role in the process of sensing insults from the environment and regulate both 
innate and adaptive immunity through the production of functional molecules and via physical 
interactions with the cells of the immune system [16]. Activation of epithelial cells results in immediate 
host defense responses by producing cytokines, growth factors, chemokines, and danger signals which 
recruit and activate other mucosal innate immune cells [17,18]. Recent evidences that allergens can 
interact with the components of the innate immune system in ways that promote Th2 response, provide a 
new pathway for investigation of allergenic sensitization. This should open novel concepts in allergen 
immunotherapy [19]. IL-33, a member of the IL-1-related cytokines, is considered to be a pro-allergenic 
molecule (an endogenous danger signal - alarmin) that is especially involved in Th2-type immune 
response [20], while thymic stromal lymphopoietin (TSLP), a member of IL-2 family of cytokines, is able 
to modulate dendritic cells (DCs) to induce the production of Th2-attracting chemokines [18].  
The aim of this study was to explore 1) structural and immunological features of MDA modified 
ovalbumin, and 2) its effects on T84 intestinal epithelial cells in terms of up-regulation of genes for pro-
inflammatory cytokines, and production of pro-allergenic IL-33 and TSLP. 
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2. Material and methods 
2.1 Molecular modeling of OVA 
To predict dynamics of OVA amino acid residues exposure to the solvent and hence their susceptibility to 
MDA modifications, molecular dynamics simulation was employed. Ten nanoseconds of unconstrained 
molecular dynamics (MD) simulations were performed using OVA structure deposited in Protein Data 
Bank, PDB ID: 1OVA [21]. N-Acetylglucosamine bound to Asn298 was retained and phosphate groups 
bound to Ser87 and Ser350 were removed. Protein was neutralized with counterions and embedded in the 
sphere of explicit water molecules (TIP3P). Input files were prepared in CHARMM-GUI [22,23], the 
CHARMM36 force field was used. The system was equilibrated in two cycles of minimization and 
heating, yielding sphere of ~ 96 Å radius. MD simulations were performed in NAMD 2.9 [24], on Linux-
based HPC facility. MD trajectories were analyzed in VegaZZ 3.1 [25]. pKa values of protonable side-
chains were estimated using PropKa 3.0 [26].  
 
2.2 Purification of OVA  
Before modification with MDA, OVA (A5253, Sigma – Aldrich, St. Luis, USA) was fractionated by gel 
filtration on a Sephadex G100 column (Pharmacia, Uppsala, Sweden, 80 mL) equilibrated with 20 mM 
sodium phosphate, 150 mM NaCl buffer pH 7.4. The fractions containing OVA were pooled and resolved 
on Fe
3+
-immobilized-metal affinity chromatography (IMAC, IDA-Sepharose 6B matrix, Clontech 
Laboratories, Inc. , Mountain View, USA) [27]. Purity of OVA (95%) was confirmed by SDS-PAGE 
analysis (12% polyacrylamide gel), which was performed as previously described [28].  
Level of endotoxin was determined by Pierce
® 
LAL chromogenic endotoxin quantification kit 
(Thermo Scientific, Rockford, USA), according to the manufactures instruction, as 3.42 EU/mg 
OVA. 
 
2.3 Modification of OVA with MDA 
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For the protein modification a fresh MDA stock solution was prepared on a daily-base according to the 
protocol described by Wu et al. [29]. To obtain the MDA stock solution 1,1,3,3-tetramethoxypropane 
(TMP, Sigma-Aldrich, St. Luis, USA) was hydrolyzed by HCl at 40 °C in the dark for 30 min. After the 
hydrolysis, the pH of the reaction mixture was adjusted to 7.4 with NaOH. The concentration of MDA 
solution was calculated by measuring absorbance at 267 nm and by using a molar extinction coefficient of 
31500 M
-1
cm
-1
. One milligram of OVA and OVA treated with increasing concentration of MDA (0.5, 1, 
2, 3, 4, 5, and 10 mM MDA) were incubated by continuous shaking for 24 h in the dark at 25 °C. After 
the treatment samples were dialyzed against deionized water at 4 °C for 72 h and lyophilized. Before 
further experiments the lyophiylized proteins were stored at 4 °C until downstream analysis. 
 
2.3.1 Measurement of carbonyl group content 
For the evaluation of carbonyl group content in control and in modified OVA, the lyophilized protein 
samples (1 mg) were resolved in 10 mM sodium phosphate buffer pH 7.0 (1 mL). 100 L of each sample 
was mixed with 300 L of 10 mM 2,4-dinitrophenylhydrazine (DNPH) dissolved in 2 M HCl and 
incubated at room temperature for 2 h. An aliquot of non-treated OVA was mixed with 300 L of 2 M 
HCl as a blank. Then, 400 L of 20% trichloroacetic acid (TCA) was added to each sample and incubated 
for 20 min at room temperature (RT); the mixture was centrifuged (12000  g for 10 min) at 4 °C. The 
supernatant was discarded, and the pellet was washed three times with 500 L of ethanol/ethyl acetate 
solution (1:1; v/v). The protein, free of DNPH, was then dissolved in 300 L of 6 M guanidine 
hydrochloride in 100 mM sodium phosphate buffer pH 7.0. The absorbance at 367 nm was corrected by 
the absorbance in the HCl as blank. The results are expressed as nanomoles of carbonyl group per 
milligram of protein. 
 
2.3.2 Fluorescence spectra of native and MDA modified OVA 
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Lyophilized protein samples were suspended in 10 mM sodium phosphate buffer pH 7.0. For 
fluorescence determination, protein concentration was adjusted to 0.04 mg/mL for tryptophan 
measurement and to 0.2 mg/mL for Schiff base measurement. To determine the fluorescence emission 
spectrum of tryptophan, the excitation wavelength was set at 290 nm, and the emission spectrum was 
recorded from 300 to 400 nm. For determination of the fluorescence emission spectrum of the Schiff base, 
the excitation wavelength was set at 350 nm, and the emission spectrum was recorded from 400 to 600 
nm. 
 
2.3.3 Mass spectrometry analysis of native and MDA modified OVA  
Mass spectra of intact proteins were obtained on Ultraflextreme MALDI TOF/TOF (Bruker, Bremen, 
Germany) operating in a linear positive mode using 2,5-dihydroxyactetophenone as a matrix. Spectra 
were calibrated with Protein standard II (Bruker 207234). 
Mass fingerprint analysis was performed as previously described [30]. In brief, intact OVA (control) and 
three samples: OVA-1MDA (OVA modified with 1 mM MDA), OVA-5MDA (OVA modified with 5 
mM MDA), OVA-10MDA (OVA modified with 10 mM MDA) were reduced with 10 mM DTT and 
alkylated with 50 mM iodoacetamide. Trypsinization was performed with sequencing grade trypsin 
(Promega, Mannheim, Germany) (w/w 1:50) in 50 mM ammonium bicarbonate, overnight at 37 °C. Prior 
to MS analysis samples were cleaned over C18 zip tip (Millipore, Massachusetts, USA). Tryptic maps 
were obtained on Ultraflextreme operating in a reflectron positive mode using α-cyano-4-
hydroxycinnamic acid as a matrix and a peptide calibration standard mixture (Bruker 206195) for mass 
calibration. Samples treated with MDA exhibited almost identical peptide mass fingerprints. The peaks 
present in control sample were subtracted from peaks present in mass spectra of samples treated with 
MDA. A resulting list of peptides was searched against list of theoretical modifications generated on an 
assumption that Lys, Arg, His, Asn and Gln can be modified with MDA [31, 32] and that trypsin will not 
cleave at Lys or Arg if they are modified with MDA. For resulting candidate peaks amino acid sequence 
and presence of modification was confirmed by MS/MS spectra obtained in a Lift mode.  
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2.4 In vitro digestion assay 
In vitro digestion assay was performed according to the protocol described by Minekus et al. [33], without 
addition of pancreatic lipase and bile salts. The final concentration of OVA and a panel of samples: OVA-
0.5MDA (OVA modified with 0.5 mM MDA), OVA-1MDA (OVA modified with 1 mM MDA), OVA-
2MDA (OVA modified with 2 mM MDA), OVA-3MDA (OVA modified with 3 mM MDA), OVA-
4MDA (OVA modified with 4 mM MDA), OVA-5MDA (OVA modified with 5 mM MDA) and OVA-
10MDA (OVA modified with 10 mM MDA) was adjusted to 0.2 mg/mL, while the final concentration of 
pepsin (Sigma Aldrich) in the simulated gastric fluid was 2000 U/mL, and the final concentration of 
trypsin (Sigma Aldrich) in the simulated intestinal fluid was 100 U/mL. The final volume of each sample 
was 100 L and incubation was performed for 2h with shaking (250 rpm) at 37 ºC. Each reaction was 
stopped by adding 25 L of 5 loading buffer for SDS-PAGE and incubation at 95 ºC for 30 min before 
application on SDS-PAGE analysis. 
 
2.5 ELISA inhibition 
IgE reactivity of MDA-modified OVA was analyzed in ELISA inhibition. Two patients with a clinical 
history of allergic reactions to egg white were included in the study. IgE-mediated allergy was 
documented by case history, skin prick test (SPT), and positive specific IgE (sIgE, CAP-FEIA, 
Pharmacia-Upjohn, Uppsala, Sweden) to egg white, and positive dot blot with OVA. The patients were 
sensitized to one or more foods. The study was performed with the approval of the Ethics Committee of 
the University Children's Hospital of Belgrade, Serbia (Approval No. 017-990/87/2012-01/19).  
The assay was performed in ELISA Maxisorp immunoplates (Nunc
TM
, Reskilde, Denmark). Briefly, each 
well was coated with OVA (100 g/mL, 100 L/well) in 15 mM Na2CO3/35 mM NaHCO3, pH 9.5, 
overnight at 4 °C. The plate was washed (3  5 min) with PBS containing 0.01 % (v/v) Tween 20 (TPBS), 
and blocked with 3% bovine serum albumin (Serva) in TPBS for 3 h at room temperature. After washing, 
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wells were incubated with the egg white allergic patient’s sera (sera 1 was diluted 1:5; sera 2 was diluted 
1:3, respectively, 100 L in TPBS) pre-incubated with a serial dilution (0, 0.01, 0.1, 1, 10, and 100 g of 
inhibitor) of OVA; OVA-1MDA (OVA modified with 1 mM MDA), and OVA-10MDA (OVA modified 
with 10 mM MDA) in TPBS, respectively. The bound IgE was detected using monoclonal alkaline 
phosphatase labeled anti-human IgE antibody (1:1000, Sigma Aldrich, St. Louis, USA). The reaction was 
visualized by using p-nitrophenylphosphate (1.0 mg /mL) in 100 mM diethanolamine buffer pH 9.6, and 
the absorbance was measured at 405 nm. All samples were analyzed in duplicates.  
 
2.6 Cell culture 
T84 cells (ATCC, Manassas, VA, USA) were grown and maintained in Dulbecco’s modified Eagle’s 
medium (DMEM, Sigma-Aldrich, St. Louis, USA), supplemented with 10% fetal bovine serum and 
penicillin (100 IU)/streptomycin (100 µg/mL) (Sigma-Aldrich, St. Louis, USA) at 37 ºC in 5% CO2 
humidified atmosphere. Cells were passaged using 0.25% trypsin solution in phosphate-buffered saline 
(PBS) without calcium and magnesium. Before each treatment, the nutritive medium was removed, the 
plates washed with PBS, and the cells incubated in serum-free medium 1 hour prior to treatment. Each 
experiment contained control monolayers, which allowed for normalization of the data and suitable 
statistical analysis to be conducted. The standard MTT test was used to ensure that treatments induced no 
significant cellular death [34]. For MTT test, T84  cells were seeded in flat-bottom 96-well plates 
(NUNC, Roskilde, Denmark) at a cell density of 1×10
4
 cells/well, and for treatments in 6-well plates 
(NUNC, Roskilde, Denmark), at a cell density of 5×10
5
 cells/well. The following treatments were filtered 
(0.22 m) and used: OVA,OVA-1MDA (OVA modified with 1mM MDA) and OVA-10MDA (OVA 
modified with 10mM MDA), all in a concentration of 0.5 mg/mL (which induced no significant cellular 
death up to 4 hours of treatment as determined by MTT test). After 4h of treatment, the supernatants were 
collected for analysis of cytokine release by ELISA, and the cells washed with PBS and collected by 
centrifugation (420  g, 10 min) for RNA isolation.  
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2.6.1 RNA isolation and RT-PCR 
Evaluation of gene expression was done by reverse-transcriptase polymerase chain reaction (RT-PCR). 
For the isolation of total RNA, cell pellets were lysed using TRI REAGENT
®
 BD kit (Sigma-Aldrich, St. 
Louis, USA). cDNA synthesis from total RNA (2 μg) was performed using random primers and 
MultiScribe™ Reverse Transcriptase from High-Capacity cDNA Reverse Transcription kit (50 U/μL, 
Applied Biosystems, Carlsbad, USA). PCR reactions (final volume 20 μL) consisted of 10 μL TaqMan 
Universal Master Mix, 300 ng cDNA and 10 pmol of primers. PCR was performed using the following 
program: 95 °C for 5 min, 35 cycles at 95 °C for 1min, Tm for 1 min, 72 °C for 30 seconds finally 7 min 
at 72 °C. The sequence of PCR primers, Tm values and the size of the obtained PCR products are given in 
Table 1. 
The presence, size and quantity of the amplified PCR products were analyzed on 2% agarose/EtBr gels 
running molecular weight markers alongside (O' Gene Ruler 100 bp DNA Ladder, Fermentas, Vilnius, 
Lithuania). Quantification of PCR band intensities was performed on samples obtained from three 
independent experiments, after normalization to the GAPDH signal using Image Studio Lite v5.2 (LI-
COR Biosciences), and presented as mean ± SEM. mRNA levels upon treatment were compared to the 
corresponding non-treated samples (taken as 1), and the graph prepared using GraphPad Prism v6.07 
(GraphPad Software).Two way analysis of variance (ANOVA) was used to compare sample means. 
When an overall statistically significant difference was seen, post-tests were performed to compare 
treatment pairs, using the Bonferroni method to adjust the p-value for multiple comparisons. Differences 
were considered significant if p  0.05. 
 
2.6.2 ELISA analysis of IL-33 and TSLP cytokines released in cell supernatants 
Detection of cytokines IL-33 and TSLP in cell culture supernatants was performed in ELISA Maxisorp 
immunoplates (Nunc
TM
, Reskilde, Denmark). For IL-33 detection, each well was coated with goat anti-
IL-33 polyclonal antibodies (20 µg/mL, 50 µL/well, BioLegend, San Siego, USA, Poly5163), and for 
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TSLP detection, anti-human TSLP antibody (20 µg/mL, 50 µL/well, BioLegend, San Diego, 
USA) in Coating buffer (CB 15 mM Na2CO3/35 mM NaHCO3, pH 9.5), overnight at 4 °C. The plates 
were washed (4  5 min) with PBS containing 0.05 % (v/v) Tween 20 - TPBS, and blocking was 
performed for 2 h at room temperature with 1% BSA in PBS. Serial dilutions of the recombinant human 
IL-33 (250 pg/mL, 50 L/well, Biolegend), the recombinant TSLP (500 pg/mL, 50 µL/well, Biolegend, 
San Diego, USA) or undiluted cell culture supernatants (50 g/well) were added to the wells and 
incubated overnight at 4 °C. After washing with TPBS (5  5 min), the biotin labeled anti-human IL33 
(20 g/mL, 50 L/well, BioLegend, San Diego, USA) or the biotin labeled anti-human TSLP (20 
µg/mL, 50 µL/well, BioLegend, San Diego, USA) in Blocking buffer was added to the wells and 
were incubated for 1 h at room temperature. After washing with TPBS (4 5 min), streptavidin-
horseradish peroxidase (1:2000 dilution, 50 L/well) in TPBS was added and incubated for 30 min at RT. 
After washing (5  5 min) with TPBS, the substrate solution 50 µL/well (ABTS (Sigma-Aldrich) 0.3 
mg/mL in 0.1 M citric acid, pH 4.35 and H2O2 in final concentration 0.03 % v/v) was added for 1 h at 37 
˚C. The reaction was stopped by the addition of 50 L of ABTS stop solution (dimethylformamide: 
ddH2O; 1:1 (v:v) with 20 % w/v SDS) and the absorbance was measured at 405 nm (reference 
wavelength 620 nm). One way analysis of variance (ANOVA) was used to compare sample 
means, and Tukey’s Multiple Comparison test was used to compare control with treatments. 
Differences were considered significant if p < 0.05. 
 
3. Results 
3.1 Prediction of MDA modified Lys side chains in OVA 
MDA primarily forms adducts with lysine residues of proteins [15], and therefore the molecular 
dynamics simulation was employed for the prediction of Lys side chains that are exposed to the 
solvent and hence susceptible to MDA modifications. For the MD simulation one subunit of 
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ovalbumin was used. During analysis of the MD trajectory we considered surface of Lys side-
chains exposed to the solvent, percentage of time during which a particular residue is exposed to 
the solvent, as well as the estimated pKa value of Lys side-chain amino groups (Table S1, in the 
Supplementary material). We found the following residues highly exposed to the solvent: Lys46, 
Lys55, Lys61, Lys92, Lys122, Lys226, Lys277 and Lys285, with surface areas > 100 Å
2 
and > 
75 % of the time. Lys16, Lys181, Lys186, Lys206, Lys263, Lys289 and Lys321 having > 70 Å
2 
and > 50 % of the time. Lys19, Lys189, Lys228, Lys279 were found as residues with side-chains 
having smallest accessibility to the solvent, while Lys367 did not appear exposed on the surface 
of the protein in MD trajectory. Position of Lys residues in OVA 3D structure experimentally 
found as modified by MDA and those for which high or low accessibility to the solvent were 
found from MD simulations is shown on Figure 1 and Figure S1 (in the Supplementary Material) 
suggest that terminal amino group of Lys16, Lys181, Lys228, Lys289 and Lys367 will be in its 
neutral form, therefore less prone to MDA modifications. 
 
3.2.1 Measurement of carbonyl group content in MDA modified OVA 
As a bifunctional aldehyde, MDA contains two reactive carbonyl groups which can react with free amino 
groups of а protein by forming Schiff base. MDA can react with a nucleophilic nitrogen or sulfur atom in 
side chain of Lys, His, Cys and Arg. Most often the final product of the MDA reaction with Lys is the 
introduction of one carbonyl group into protein per MDA molecule. In addition, MDA is capable to cross-
link proteins via Schiff base formation, and to produce fluorescent adducts such as 
dihydropyridine(DHP)-Lys [15]. The content of protein carbonyl groups was evaluated by DNPH (Table 
2). The level of carbonyl group in OVA was 1.73 nM/mg, while there was gradual increase in the level of 
carbonyl groups with the increase of MDA concentration (p 0.05). The carbonyl content increased 
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almost 5-fold after OVA treatment with 1 mM MDA, 15-fold after OVA was treated with 5mM of MDA, 
and 23-fold after treatment with 10 mM MDA for 24 h at room temperature. 
 
3.2.2 Fluorescence spectra  
Tryptophan residue emits fluorescence in the range of 300-400 nm after excitation at 290 nm. DNPH - 
Schiff base is a conjugated fluorochrome with an excitation maximum about 350 nm and an emission 
maximum about 460 nm [35]. Profiles of Schiff base and tryptophan fluorescence emission spectra of 
MDA modified OVAs are shown in Figure 2. With the increasing concentration of MDA the fluorescence 
from the Schiff base increased (Fig. 2a) while the fluorescence from tryptophan decreased (Fig 2b). This 
finding is in agreement with findings related to studies on the effects of MDA on proteins fluorescence 
[36, 37]. The decrease in tryptophan fluorescence could be attributed to the change in the local 
environment of tryptophan residues due to the binding of the aldehyde to the OVA [37, 38].The 
increasing fluorescence in 460 nm is attributed to the Schiff formation, as a consequence of MDA 
interaction with free amino groups in the OVA. 
 
3.2.3 Mass spectrometry analysis  
Mass spectrometry analysis of intact OVA and OVA modificates indicated an increase in molecular mass 
of the protein as the MDA concentration increased (Fig. S2). 
OVA and OVA modified with 1 mM, 5 mM and 10 mM MDA were reduced, alkylated and digested by 
trypsin. By mass spec analysis following OVA peptides with modified Lys were identified: 
51
TQINKVVR
58
, 
85
DILNQITKPNDVYSFSLASR
104
, 
111
YPILPEYLQCVKELYR
126
, 
187
AFKDEDTQAMPFR
199
, 
277
KIKVYLPR
284
, and 
278
IKVYLPR
284
. Two types of MDA adducts on Lys 
residues were identified: MDA Schiff base (+54 Da) and MDA dihydropyridine(DHP) adduct(+134 Da). 
Details on the type of modification and Lys position are given in Table 3. Tryptic OVA peptide 
51
TQINKVVR
58
was detected with [M+H]
+
m/z value 1091.4 Da (Figure S3a). By MS/MS analysis 
dihydropyridine type of MDA adduct (+134 Da) was detected at K55. Both types of adducts were 
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detected for Lys92 in 
85
DILNQITKPNDVYSFSLASR
104
 with [M+H]
+
m/z values of 2335.2 Da (Fig. S3b) 
and 2415.22 Da (Fig. 3), respectively. In peptide 
111
YPILPEYLQCVKELYR
126 
MDA 
dihydropyridine(DHP) adduct (+134 Da) was in position Lys122,with [M+H]
+
m/z value 2218.1 Da (Fig. 
S3c). Peptide 
187
AFKDEDTQAMPFR
199 
with [M+H]
+
m/z value 1609.69 Da (Fig. S3d) bears MDA Schiff 
base adduct (+54 Da) in Lys189. Interestingly, in peptide 
277
KIKVYLPR
284
 Lys277 and Lys279 were both 
modified either in a form of DHP adducts with [M+H]
+
m/z value 1284.72 Da (Fig. 3e), or as a 
combination with Lys277 in a form of DHP adduct and Lys279 in a form of Schif base, with [M+H]
+
m/z 
value 1204.69 Da (Fig. S3f). In peptide 
278
IKVYLPR
284
Schiff base adduct at Lys279 was detected with 
[M+H]
+
m/z value 942.55 Da (Fig. S3g). Although the search against list of theoretical modifications was 
based on the assumption that beside Lys, amino acid residues of Arg, His, Asn and Gln can also be 
modified, we fail to detect such modifications.  
 
3.3 Simulated gastro-duodenal digestion of MDA-modified OVA  
Electrophoretic profiles of OVA modified with increasing concentration of MDA (0.5 mM, 1 mM, 2 mM, 
3 mM, 4 mM, 5 mM, and 10 mM) denoted as: OVA-0.5MDA, OVA-1MDA, OVA-2MDA, OVA-
3MDA, OVA-4MDA, OVA-5MDA, and OVA-10MDA are shown in Figure 4. No precipitation of OVA 
protein was observed in the reaction mixtures after MDA modification. Besides monomeric protein band 
of about 45 kDa, bands above 116 kDa corresponding to OVA oligomers were detected in MDA modified 
OVA. The intensity of oligomers derived from cross-linking of OVA protein increased with the 
concentration of MDA. The intensity of the monomeric form was reduced, although it could be a 
consequence of altered binding of CBB for MDA modified OVA, as it was shown for MDA modified 
BSA [39]. 
Digestion stability of MDA modified OVA after being incubated in simulated gastric and simulated 
duodenal conditions was analyzed by SDS-PAGE. The MDA modified OVA samples were incubated for 
2 h in the simulated gastric as well as for 2 h in the simulated duodenal conditions. Under applied 
experimental conditions considerable amounts of MDA modified OVA remain undigested (Fig. S4).  
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3.4 ELISA inhibition 
Effect of MDA modifications on IgE reactivity of OVA was tested in ELISA inhibition. Two patient’s 
sera were employed in the assay. Intact OVA was coupled to the solid phase, while the egg white 
patient’s sera was preincubated with serially diluted OVA, OVA-1MDA, and OVA-10MDA, respectively 
before addition to the plate. Figure 5 shows inhibition of IgE binding to non-modified OVA, which is 
obtained with increasing concentrations of OVA, OVA modified with 1mM MDA, and OVA modified 
with 10 mM MDA. All the inhibition curves followed the same trend, i.e. the inhibition of IgE binding 
increased together with the amount of added inhibitor. In both sera the OVA-specific IgE showed higher 
affinity for non-modified OVA comparing to OVA treated with MDA. Interestingly, OVA and OVA-
1MDA revealed comparable IC50 with sera 1, while OVA-10MDA revealed lower inhibitory potential. 
Gradual decline in IC50 values was observed for OVA, OVA-1MDA and OVA-10MDA with sera 2. 
 
3.5.1 MDA modified OVA induced mRNA cytokine expression in T84 epithelial cells 
To address the question whether OVA and MDA modified OVA can interact with intestinal epithelial 
cells in a way which may promote the epithelial specific pro-inflammatory immune response, T84 
epithelial cells were incubated with the allergen samples (OVA, OVA-1MDA, and OVA-10MDA) for 4 
h. In order to assess whether such treatment had any effect on cytokine gene expression, mRNA levels for 
IL-1β, IL-6, IL-25, IL-33, TSLP and TNFα from treated samples were compared to non-treated controls 
(Fig. 6). After normalization to the corresponding GAPDH signal, quantitative analysis showed a general 
up regulation of IL-1β, IL-6, IL-25, IL-33, TSLP and TNFα in cells treated with OVA. OVA-1MDA also 
induced an up regulation of these genes, except in the case of IL-6, where a down regulation was 
observed. OVA-10MDA induced a general down regulation of these genes, except in the case of IL-1β 
where an up-regulation was observed. 
 
3.5.2 MDA modified OVA induced IL-33 expression  
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Epithelial cells are a potential source of IL-33, a crucial amplifier of innate immunity, and therefore it was 
interesting to compare the effect of intact OVA and MDA modified OVA on T84 cells in terms of 
production of IL-33. ELISA was performed to test whether MDA modified OVA besides up-regulation of 
cytokine gene expression, induced similar effects on the protein level, i.e. production of IL-33 and TSLP 
cytokines (Fig. 7). The level of IL-33 in the medium of T84 cells treated with OVA was 69.9 pg/mL 
while OVA-1MDA, and OVA-10MDA induced lower secretion of IL-33 in the medium of 60.4 pg/mL 
and 47.6 pg/mL, respectively. The level of TSLP that was induced by cell treatment with OVA-1MDA 
was lower when compared to the TSLP induced by OVA, while induction of TSLP with OVA-10MDA 
was not statistically significant (Fig. 8).  
 
4. Discussion 
The effect of MDA, a secondary polyunsaturated fatty acid oxidation product, on major egg 
white allergen ovalbumin was studied in terms of structural changes and consequent effects on 
IgE reactivity, as well as immunomodulatory potential of modified allergen on T84 gut epithelial 
cells.  
From the analysis of the MD trajectory we found Lys46, Lys55, Lys61, Lys92, Lys122, Lys226, 
Lys277 and Lys285 as good candidates for the MDA derivatization. Lys residues identified by 
MS/MS analyses as modified with MDA were: Lys55, Lys92, Lys122, Lys189, Lys277 and 
Lys279. In Figure 1 and in Figures 1S (Supplementary Material), all OVA Lys side chains are 
shown. In Figure 1S protein is shown in CPK representation, in this way accessibility of different 
Lys side chains is emphasized. So, our predictions of Lys side-chains prone for modifications 
with MDA are in agreement with experimental results for Lys55, Lys92, Lys122 and Lys277, 
while prediction failed for Lys189 and Lys279. The last two residues are close to very flexible 
OVA R-helix, characteristic for the proteins belonging to the serpin family. In our simulations 
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this helix retained its helical structure, most probably because of constraints imposed on two 
atoms close to the center of the mass of the protein. Such constraint is imposed in order to 
preclude movement of the whole system during simulations; in this way the analysis of the MD 
trajectory is facilitated. In simulations without such constraint R-helix appears significantly more 
mobile and Lys189 appears exposed to the solvent to a significantly higher extent. We cannot 
offer an explanation for the incorrect prediction of Lys279, but the close proximity of Lys277 
and Lys279 should be noted.  
Two distinct types of MDA adducts were detected in OVA upon tryptic digestion, with mass 
increments of 54 Da and 134 Da that correspond to Schiff base and dihydropyridine (DHP)-type 
adducts, respectively. There were no remarkable differences in digestion stability of OVA and 
MDA modified OVA in the simulated gastric and duodenal digestion under employed 
experimental conditions. To get better insight is eventual differences perhaps the test should be 
performed in the presence of bile salts and lipase, as it has been documented that bile salts can 
promote the digestion of several dietary proteins [40]. Although IgE reactivity was evaluated 
with only two patient’s sera, the trend of IgE reactivity seems to be declining with the increase of 
level of MDA modifications in OVA, which should be attributed to the masking and/or steric 
hindrance of the IgE binding epitopes. In this regard, reduced IgE reactivity of MDA modified 
OVA is in line with the report for MDA modified shrimp allergen tropomyosin [41].  Schiff base 
adduct found in position Lys92 might have an impact on IgE binding for the immunodominant 
epitope AA95-102, while modification of Lys189 could influence IgE binding for epitope 
AA191-200. However, the modified surface topography of OVA-1MDA revealed no effect on 
IC50 value for sera 1 obtained in ELISA inhibition.  
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The concept, held for many years, that the surface epithelia contribute to host protection strictly 
as a physical and chemical barrier is being revised owing to accumulated evidence that epithelial 
cells can activate tissue-associated lymphocytes and that the epithelial cells response to infection 
and/or stress can strongly influence dendritic cells and subsequent adaptive immune responses 
[42]. There is increasing evidence highlighting the role of epithelial cells in triggering and 
modulating immune response to allergens [18]. A range of cytokines including TSLP, IL-33, IL-
25, IL-1, and granulocyte macrophage colony-stimulating factor (GM-CSF) are known to be 
secreted by airway epithelial cells after allergen challenge [18, 43, 44]. Most of the data which 
deals with specific interactions of allergens with epithelial cells are based on interactions on 
respiratory allergens with the airway epithelium. However, the mechanism by which food 
allergens induce sensitization and afterward specific IgE responses in patients with food allergy 
are poorly understood [45]. Therefore food allergen research has been focused on the elucidation 
of structural features of allergens in an effort to delineate the specific characteristics 
differentiating allergenic from nonallergenic food components, and to determine how food 
processing can enhance or reduce the ability of food allergens to induce food allergy [46]. 
In this study we explored the effects of introduced covalent modifications on allergen 
interactions with epithelial cells. We tested the immunomodulatory effect of MDA modified 
OVA on epithelial cells by employing T84 colorectal adenocarcinoma cells. Treatment of the 
T84 cells with OVA allergen induced up-regulation of genes for cytokines IL-1β, IL-6, IL-25, IL-
33, TSLP and TNFα. A similar trend was observed for the set of analyzed cytokine genes, except for IL-
6, in T84 cells treated with OVA modified with 1mM MDA. OVA modified with 10 mM MDA induced a 
general down-regulation of these genes, except IL-1β where an up-regulation was observed.  
Among the Th2 modulating cytokines produced by epithelial cells IL-33 has been identified as a ligand 
for ST2, an IL-1R-related protein specifically expressed on the surface of Th2 cells, which belongs to the 
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Toll-like receptor superfamily [20]. IL-33 can polarize naïve T cells to produce IL-5 and IL-33, while 
treatment of Th2 cells with IL-33 enhanced IL-5 and IL-13 production. In addition, dendritic cells 
respond to IL-33 by up regulating cell-surface expression of MHC class II molecules and the co-
stimulatory molecule CD86 [47]. Besides IL-33, human epithelial cells can produce TSLP in response to 
diverse stimuli including microbes, trauma, or inflammation. It seems that TSLP might initiate and 
aggravate allergic inflammation in the absence of T lymphocytes and IgE, via the innate immune system 
i.e. activation of mast cells [48]. 
ELISA was performed to test the effect of OVA and MDA modified OVA on T84 cells in terms of 
secretion of IL-33 and TSLP. Results indicate that OVA induce secretion of IL-33 by T84 epithelial cells 
after 4 hours of allergen incubation. Treatment of T84 cells with OVA-1MDA, and OVA-10MDA 
slightly reduced the level of IL-33 in the medium. However, up-regulation profile of TSLP which was 
detected at the mRNA level was not confirmed in ELISA at the protein level for the analyzed time-frame 
(4h of incubation). Interestingly, Tani et al. investigated the immunochemical properties of proteins 
reacted with MDA [49]. They observed a different profiling of the specific IgE and IgG response after 
immunization of mice with native OVA and MDA modified OVA. Both the IgE and IgG antibody 
response to the native OVA was higher than anti-MDA-OVA. The profile of the antibody response was 
found completely opposite for bovine serum albumin and -lactoglobulin (-LG) where IgE and IgG 
response was significantly higher to anti-MDA-BSA and anti-MDA--LG than that of anti-BSA and anti-
-LG. These findings are in line with our results for OVA and MDA modified OVA effects on secretion 
of IL-33 from T84 intestinal epithelial cells.   
In conclusion, MDA modification of food allergen ovalbumin induced structural changes on Lys residues, 
which contributed to the reduced IgE reactivity of the protein. Ovalbumin induced secretion of pro-
allergenic IL-33 cytokine in T84 cells, which can contribute to the development of Th2 immune response. 
Structural modifications of OVA slightly reduced production of IL-33, which indicates that probably 
particular molecular features facilitate recognition of this allergen by T84 intestinal epithelial cells. To the 
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best of our knowledge this is the first evidence that ovalbumin, without the presence of adjuvants induces 
IL-33 cytokine secretion in a model of intestinal epithelial cell line. Deeper insight into the molecular 
basis of early events in food allergen sensitization should lead to the development of more effective 
therapeutic strategies for allergic diseases.  
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Figure captions 
Figure 1. Lys residues mapped on the OVA surface. The following coloring of Lys residues was 
used: green - predicted as highly reactive and experimentally found as modified by MDA;  
turquoise - experimentally found as modified by MDA, but predicted as poorly reactive; blue - 
predicted as highly reactive but experimentally found as unmodified by MDA; orange - predicted 
as moderately reactive; red - predicted as poorly accessible to the solvent/poorly reactive. 
Figure 2. Fluorescent emission spectra of Schiff base (A) and tryptophan (B) of OVA modified 
with increasing concentration of MDA: 1) control; 2) 0.5 mM MDA; 3) 1 mM MDA; 4) 2 mM 
MDA; 5) 3 mM MDA; 6) 4 mM MDA; 7) 5 mM MDA; 8) 10 mM MDA. 
Figure 3. MS/MS spectra of OVA tryptic peptide carrying modified lysine residue. Modified lysine 
residue is marked with an asterisk. Detected y and b ions, with their masses, are shown on peptide 
sequence. 
Figure 4. SDS-PAGE profiles of control and MDA-modified OVA: 1) OVA, 2) OVA-0.5MDA, 3) OVA-
1MDA, 4) OVA-2MDA, 5) OVA-3MDA, 6) OVA-4MDA, 7) OVA-5MDA, 8) OVA-10MDA; MM) 
molecular markers. 
Figure 5. IgE ELISA Inhibition: as an inhibitor for IgE binding was used OVA, OVA-1MDA, and OVA-
10MDA.  
Figure 6. Analysisof gene expression by RT-PCR.C – control (non-treated) cells, OVA – cells treated 
with ovalbumin, OVA-1MDA  – cells treated with 1mM MDA pre-treated ovalbumin, OVA-10MDA - 
cells treated with 10mM MDA pre-treated ovalbumin.* p<0.05, ** p<0.01. 
Figure 7. Quantification of IL33 in supernatants of T84 cells treated with OVA, 1MDA-OVA, and 
10MDA-OVA in ELISA. All the tests were performed in duplicate and results are presented as 
mean ± SEM. 
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Figure 8. Quantification of TSLP in supernatants of T84 cells treated with OVA, 1MDA-OVA, and 
10MDA-OVA in ELISA. All the tests were performed in duplicate and results are presented as 
mean ± SEM. 
TABLES 
Table 1. Sequences of PCR primers, Tms and sizes of the corresponding PCR products of the analyzed 
genes. 
Table 2. Carbonyl group content of control and MDA modified OVA was evaluated after DNPH 
treatment by measuring the absorbance at 367 nm.   
Table 3. Type and position of modified lysines in OVA sequence (UniProtKB AC: P01012) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 Effects of MDA on the ovalbumin interactions with T84 epithelial cells 
29 
 
 
Table 1. 
Gene  GenBank 
Accession No.  
Tm  
(°C)  
Primer sequence  
(5’-….-3’)  
PCR product 
size (bp)  
IL-1β  NM_000576.2  49  AACCTCTTCGAGGCACAAGG  
GGCGAGCTCAGGTACTTCTG  
137  
IL-6  NM_000600.3  49  ACCCCCAATAAATATAGGACTGGA  
GAGAAGGCAACTGGACCGAA  
145  
IL-25  NM_022789.3  49  CCAGGTGGTTGCATTCTTGG  
TGGCTGTAGGTGTGGGTTCC  
51  
IL-33  NM_033439.3  51  CACCCCTCAAATGAATCAGG  
GGAGCTCCACAGAGTGTTCC  
115  
TSLP  NM_033035.4  51  TATGAGTGGGACCAAAAGTACCG  
GGGATTGAAGGTTAGGCTCTGG  
97  
TNFα  NM_000594.3  49  GACAAGCCTGTAGCCCATGT  
CTCTGATGGCACCACCAACT  
107  
GAPDH  NM_002046.5  65  AGCAATGCCTCCTGCACCACCAAC  
CCGGAGGGGCCATCCACAGTCT  
132  
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Table 2.  
MDA concentration 
[mM] 
Protein dry mass after 
MDA treatment [mg] 
Absorbance at 367 nm  Carbonyl group content 
[nM/mg proteins] 
0 0.65 0.0247 1.73 
0.5 0.65 0.1174 8.21 
1 0.65 0.1191 8.33 
2 0.6 0.1708 12.94 
3 0.6 0.2222 16.83 
4 0.55 0.2817 23.28 
5 0.55 0.3045 25.17 
10 0.5 0.4492 40.84 
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Table 3. 
Position of 
tryptic 
peptide in 
OVA 
sequence 
Sequence of tryptic peptide 
containing modified lysine (K*) 
Modified 
lysine 
position in 
OVA 
sequence 
Mass  of 
tryptic 
peptide 
containing 
modified 
lysine [M+H]
+
 
(Da) 
MS/MS spectra 
confirming 
type and 
position of 
modification 
51-58 TQINK*VVR K55 1091.40 S1 
85-104 DILNQITK*PNDVYSFSLASR K92 2335.20 S2 
85-104 DILNQITK*PNDVYSFSLASR K92 2415.22 S2a 
111-126 YPILPEYLQCamVK*ELYR K122 2218.10 S3 
187-199 AFK*DEDTQAMPFR K189 1609.69 S4 
277-284 K*IK*VYLPR K277, K279 1204.69 S5 
277-284 K*IK*VYLPR K277, K279 1284.72 S5a 
278-284 IK*VYLPR K279 942.55 S6 
K* - malonaldehyde Schiff base adduct (+54 Da)  
K* - malonaldehyde dihydropyridine type adduct (+134 Da)  
Cam – alkylated Cys (+57.02 Da)  
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Fig. 1 
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Fig. 2a 
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Fig. 2b 
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Fig. 3 
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Fig. 4 
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Fig. 5 
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Fig. 6 
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Fig. 7 
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Fig. 8 
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Highlights 
Malondialdehyde (MDA) covalently modifies Lys residues in OVA. 
MDA modified OVA reveals reduced IgE reactivity.  
OVA induced gene expression of pro-inflammatory cytokines in T84 epithelial cells. 
OVA and MDA modified OVA induced secretion of IL-33 in T84 epithelial cells. 
